Cargando…
Chemical proteomics: terra incognita for novel drug target profiling
The growing demand for new therapeutic strategies in the medical and pharmaceutic fields has resulted in a pressing need for novel druggable targets. Paradoxically, however, the targets of certain drugs that are already widely used in clinical practice have largely not been annotated. Because the ph...
Autores principales: | Huang, Fuqiang, Zhang, Boya, Zhou, Shengtao, Zhao, Xia, Bian, Ce, Wei, Yuquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sun Yat-sen University Cancer Center
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777519/ https://www.ncbi.nlm.nih.gov/pubmed/22640626 http://dx.doi.org/10.5732/cjc.011.10377 |
Ejemplares similares
-
The interaction map of yeast: terra incognita?
por: Mellor, Joe, et al.
Publicado: (2006) -
Material Culture: Still ‘Terra Incognita’ for Psychology Today?
por: Moro, Christiane
Publicado: (2015) -
Further reducing terra incognita on the map of synaptic autoimmunity
por: Prüss, Harald
Publicado: (2018) -
Chronic pancreatitis and the heart disease: Still terra incognita?
por: Nikolic, Sara, et al.
Publicado: (2019) -
Cardiac Involvement in Connective Tissue Disorders: Terra Incognita
por: Podlesnikar, Tomaž, et al.
Publicado: (2019)